Page last updated: 2024-09-02

quinaprilat and bradykinin

quinaprilat has been researched along with bradykinin in 13 studies

Compound Research Comparison

Studies
(quinaprilat)
Trials
(quinaprilat)
Recent Studies (post-2010)
(quinaprilat)
Studies
(bradykinin)
Trials
(bradykinin)
Recent Studies (post-2010) (bradykinin)
9223414,1953551,520

Protein Interaction Comparison

ProteinTaxonomyquinaprilat (IC50)bradykinin (IC50)
B2 bradykinin receptorHomo sapiens (human)0.0018

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's9 (69.23)18.2507
2000's4 (30.77)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bara, AT; Busse, R; Hecker, M; Pörsti, I1
Jackson, B; Johnston, CI; Perich, RB1
Drexler, H; Hornig, B; Kohler, C1
Haefeli, WE; Linder, L; Lüscher, TF1
Anning, PB; Grocott-Mason, RM; Lewis, MJ1
Arakawa, N; Drexler, H; Hornig, B1
Abiko, Y; Hara, A; Hashizume, H; Ma, H; Yazawa, K1
Allegrini, PR; Buser, PT; Hornstein, PS; Zaugg, CE; Zhu, P1
Adnot, S; Belhassen, L; Benacerraf, S; Carville, C; Dubois-Randé, JL; Montagne, O; Sediame, S1
Fujita, N; Manabe, H; Masui, Y; Matsumoto, N; Naito, Y; Ochiai, J; Uemura, M; Yoshida, N; Yoshikawa, T1
Danser, AH; de Vries, R; Saxena, PR; Tom, B1
Batenburg, WW; Danser, AH; de Bruijn, RJ; de Vries, R; Dive, V; Georgiadis, D; Tom, B; van Esch, JH; van Gool, JM; Yiotakis, A1
de Bruin, RJ; Deinum, J; Dive, V; Hectors, M; Jan Danser, AH; Montgomery, HE; Payne, JR; van Esch, JH; van Gool, JM1

Reviews

1 review(s) available for quinaprilat and bradykinin

ArticleYear
Effect of ACE inhibition on endothelial dysfunction in patients with chronic heart failure.
    European heart journal, 1998, Volume: 19 Suppl G

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Coronary Disease; Endothelium, Vascular; Heart Failure; Humans; Isoquinolines; Nitric Oxide; Tetrahydroisoquinolines; Treatment Outcome; Vasodilation

1998

Trials

1 trial(s) available for quinaprilat and bradykinin

ArticleYear
Improvement of bradykinin endothelium-mediated vasodilation of forearm resistance circulation by quinaprilat in patients with coronary artery disease with or without left ventricular dysfunction.
    Journal of cardiovascular pharmacology, 1999, Volume: 34, Issue:3

    Topics: Acetylcholine; Adult; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Bradykinin; Coronary Angiography; Coronary Disease; Dose-Response Relationship, Drug; Drug Interactions; Endothelium, Vascular; Forearm; Humans; Isoquinolines; Male; Middle Aged; Platelet Aggregation Inhibitors; Regional Blood Flow; Renin; Tetrahydroisoquinolines; Vasodilation; Vasomotor System; Ventricular Dysfunction, Left

1999

Other Studies

11 other study(ies) available for quinaprilat and bradykinin

ArticleYear
Release of nitric oxide by angiotensin-(1-7) from porcine coronary endothelium: implications for a novel angiotensin receptor.
    British journal of pharmacology, 1994, Volume: 111, Issue:3

    Topics: Amino Acid Sequence; Angiotensin I; Angiotensin II; Animals; Arginine; Bradykinin; Coronary Vessels; Endothelium, Vascular; In Vitro Techniques; Isoquinolines; Molecular Sequence Data; Muscle Relaxation; Nitric Oxide; Nitroarginine; Peptide Fragments; Receptors, Angiotensin; Swine; Tetrahydroisoquinolines; Vasodilator Agents

1994
Structural constraints of inhibitors for binding at two active sites on somatic angiotensin converting enzyme.
    European journal of pharmacology, 1994, Feb-15, Volume: 266, Issue:3

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Binding Sites; Binding, Competitive; Bradykinin; Dipeptides; Indoles; Isoquinolines; Kidney; Lisinopril; Lung; Male; Peptidyl-Dipeptidase A; Pyridazines; Radioligand Assay; Rats; Rats, Sprague-Dawley; Substrate Specificity; Testis; Tetrahydroisoquinolines

1994
Role of bradykinin in mediating vascular effects of angiotensin-converting enzyme inhibitors in humans.
    Circulation, 1997, Mar-04, Volume: 95, Issue:5

    Topics: Adult; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Bradykinin; Bradykinin Receptor Antagonists; Drug Interactions; Endothelium, Vascular; Female; Humans; Hyperemia; Isoquinolines; Male; Nitroprusside; Radial Artery; Regional Blood Flow; Tetrahydroisoquinolines; Ultrasonography, Doppler; Vasodilation

1997
Quinaprilat induces arterial vasodilation mediated by nitric oxide in humans.
    Hypertension (Dallas, Tex. : 1979), 1997, Volume: 30, Issue:4

    Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Arteries; Bradykinin; Female; Humans; Isoquinolines; Male; Nitric Oxide; Nitroprusside; Regional Blood Flow; Tetrahydroisoquinolines; Vasodilation; Vasodilator Agents

1997
Effects of sulphydryl- and non-sulphydryl-containing ACE inhibitors on left ventricular relaxation in the isolated guinea pig heart.
    Endothelium : journal of endothelial cell research, 1997, Volume: 5, Issue:4

    Topics: Acetylcysteine; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Bradykinin Receptor Antagonists; Captopril; Diastole; Female; Free Radical Scavengers; Guinea Pigs; Heart Ventricles; Hemoglobins; Isoquinolines; Lisinopril; Male; Muscle Relaxation; Nitric Oxide; Receptor, Bradykinin B2; Simethicone; Stroke Volume; Sulfhydryl Compounds; Superoxide Dismutase; Systole; Tetrahydroisoquinolines; Ventricular Dysfunction, Left

1997
Protective effect of quinaprilat, an active metabolite of quinapril, on Ca2+-overload induced by lysophosphatidylcholine in isolated rat cardiomyocytes.
    Japanese journal of pharmacology, 1999, Volume: 79, Issue:1

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Calcium; Cell Size; Creatine Kinase; Enalapril; Enalaprilat; Isoquinolines; Lysophosphatidylcholines; Male; Micelles; Myocardium; Propranolol; Quinapril; Rats; Rats, Sprague-Dawley; Tetrahydroisoquinolines; Vasodilator Agents

1999
Bradykinin-dependent cardioprotective effects of losartan against ischemia and reperfusion in rat hearts.
    Journal of cardiovascular pharmacology, 1999, Volume: 33, Issue:5

    Topics: Adenosine Triphosphate; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Coronary Circulation; In Vitro Techniques; Isoquinolines; Losartan; Male; Myocardial Reperfusion Injury; Myocardium; Phosphocreatine; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Tetrahydroisoquinolines; Ventricular Function, Left; Ventricular Pressure

1999
Inhibition of angiotensin-converting enzyme protects endothelial cell against hypoxia/reoxygenation injury.
    BioFactors (Oxford, England), 2000, Volume: 11, Issue:4

    Topics: Angiotensin-Converting Enzyme Inhibitors; Aorta; Apoptosis; Bradykinin; Caspase 3; Caspases; Cell Hypoxia; Cell Line; Endothelium, Vascular; Enzyme Activation; Enzyme Inhibitors; Humans; Isoquinolines; L-Lactate Dehydrogenase; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Oxygen; Reactive Oxygen Species; Reperfusion Injury; Tetrahydroisoquinolines

2000
Bradykinin potentiation by angiotensin-(1-7) and ACE inhibitors correlates with ACE C- and N-domain blockade.
    Hypertension (Dallas, Tex. : 1979), 2001, Volume: 38, Issue:1

    Topics: Adolescent; Adult; Angiotensin I; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Captopril; Coronary Vessels; Drug Synergism; Female; Humans; In Vitro Techniques; Isoquinolines; Male; Peptide Fragments; Peptidyl-Dipeptidase A; Protein Structure, Tertiary; Receptor, Bradykinin B2; Receptors, Bradykinin; Swine; Tetrahydroisoquinolines; Vasodilation

2001
Selective angiotensin-converting enzyme C-domain inhibition is sufficient to prevent angiotensin I-induced vasoconstriction.
    Hypertension (Dallas, Tex. : 1979), 2005, Volume: 45, Issue:1

    Topics: Adolescent; Adult; Angiotensin I; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Captopril; Coronary Vessels; Dose-Response Relationship, Drug; Female; Femoral Artery; Humans; Male; Microcirculation; Middle Aged; Oligopeptides; Organ Specificity; Peptidyl-Dipeptidase A; Phosphinic Acids; Protein Structure, Tertiary; Solubility; Structure-Activity Relationship; Sus scrofa; Tetrahydroisoquinolines; Vasoconstriction

2005
Different contributions of the angiotensin-converting enzyme C-domain and N-domain in subjects with the angiotensin-converting enzyme II and DD genotype.
    Journal of hypertension, 2008, Volume: 26, Issue:4

    Topics: Adult; Aged; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Coronary Vessels; Enzyme Activation; Female; Genotype; Humans; In Vitro Techniques; Male; Middle Aged; Oligopeptides; Peptidyl-Dipeptidase A; Phosphinic Acids; Point Mutation; Protein Structure, Tertiary; Sus scrofa; Tetrahydroisoquinolines; Vasoconstrictor Agents; Vasodilator Agents

2008